Assistant Professor, Ob/Gyn and Reproductive Science, University of Pittsburgh School of Medicine
Obstetrics & Gynecology
Dr. Thomas C. Krivak, MD
|
|
Give Review
Thomas Krivak works in the field of Obstetrics & Gynecology. He graduated from The Ohio State University College of Medicine. He received awards:"Regional Top Doctor", "Most Compassionate Doctor" and "Fellow (FACOG)". Thomas Krivak is a published MD as well. He has 80 publications published. The latest was: Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analys... He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analys...
- Cost-utility comparison of neoadjuvant chemotherapy versus primary debulking surgery for treatment of advanced-stage ovarian Cancer in patients 65 years old or older.
- A cost-effectiveness analysis of a chemoresponse assay for treatment of patients with recurrent epithelial ovarian Cancer.
- Patterns of care and brachytherapy boost utilization for vaginal Cancer in the United States.
- Adoption and impact of concurrent chemoradiation therapy for vaginal Cancer: A National Cancer Data Base (NCDB) study.
- National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements.
- Evaluation of a chemoresponse assay as a predictive marker in the treatment of recurrent ovarian Cancer: further analysis of a prospective study.
- Oxaliplatin salvage for recurrent ovarian Cancer: A single institution's experience in patient populations with platinum resistant disease or a history of platinum hyp...
- The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian Carcinoma: A Gynecologic Oncology Group study.
- Impact of facility volume on therapy and survival for locally advanced Cervical cancer.
- A prospective study evaluating the clinical relevance of a chemoresponse assay for treatment of patients with persistent or recurrent ovarian Cancer.
- Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and Cancer cell lines.
- Upper abdominal procedures in advanced stage ovarian or primary peritoneal Carcinoma patients with minimal or no gross residual disease: An analysis of Gynecologic Onc...
- The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial Cancers.
- Dual-console robotic surgery: a new teaching paradigm.
- Palliative care education in Gynecologic oncology: A survey of the fellows.
- Upfront treatment of locally advanced Cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: A cost-effectiveness analysis.
- BRCA1 expression and improved survival in ovarian Cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
- Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature Ovarian insufficiency in female mice treated with alkylating chemother...
- Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse.
- BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian Cancer.
- Pre-Treatment Tumor Expression of ERCC1 in Women with Advanced Stage Epithelial Ovarian Cancer is Not Predictive of Clinical Outcomes: A Gynecologic Oncology Group Study.
- Surgery Versus Radiation Therapy for Stage IB2 Cervical Carcinoma: A Population-Based Analysis.
- Mucinous Tumors of the Ovary: Diagnostic Challenges at Frozen Section and Clinical Implications.
- Endometrial Stromal Sarcoma: analysis of recurrence following adjuvant treatment.
- Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian Cancer treated with platinum and taxane-based chemotherap...
- Intraperitoneal chemotherapy for recurrent epithelial ovarian Cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
- Should stage IIIC ovarian Cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: A Gynecologic Oncology Group study.
- Re: Implications of upper abdominal disease in advanced ovarian Cancer after surgical cytoreduction and relation with tumor biology.
- Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian Cancer: brief rep...
- The impact of disease distribution on survival in patients with stage III epithelial ovarian Cancer cytoreduced to microscopic residual: A gynecologic oncology group s...
- Consolidation paclitaxel is more cost-effective than bevacizumab following upfront treatment of advanced epithelial ovarian Cancer.
- 3D image-based HDR interstitial brachytherapy for vaginal Cancer.
- Single nucleotide polypmorphisms in ERCC1 are associated with disease progression, and survival in patients with advanced stage Ovarian and primary peritoneal carcinom...
- Pharmacologic and phenotypic study of docetaxel in patients with ovarian or primary peritoneal Cancer.
- Proteomic analysis of ovarian Cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation.
- Ovarian Cancer screening and early detection in the general population.
- Impact of a chemoresponse assay on treatment costs for recurrent ovarian Cancer.
- Intraperitoneal catheter leads to prolongation of the time to Normalization of serum CA125 levels.
- Definitive radiation therapy for endometrial Cancer in medically inoperable elderly patients.
- Chemosensitivity testing with ChemoFx and overall survival in primary ovarian Cancer.
- Does the number of nodes removed impact survival in vulvar Cancer patients with node-negative disease?
- Completion of intraperitoneal chemotherapy in advanced ovarian Cancer and catheter-related complications.
- A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian Cancer treated with intraperitoneal compared to intrave...
- Diffuse laminar endoCervical glandular hyperplasia: a case report.
- High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial Cancer: 10-year results.
- Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar Carcinoma.
- Survival for stage IB Cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
- Pregnancy after tumor debulking and intraperitoneal cisplatin for appendiceal carcinoid tumor.
- Venous thromboembolism in obstetrics and gynecology.
- Erythropoietin receptor function and expression in epithelial ovarian Carcinoma.
- Pelvic sidewall adenoCarcinoma after definitive therapy for cervical adenoCarcinoma in situ.
- The utility of hand-assisted laparoscopy in ovarian Cancer.
- Tubo-Ovarian abscess: diagnosis, medical and surgical management.
- Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the Uterine corpus.
- Successful management of metastatic placental site trophoblastic tumor with multiple pulmonary resections.
- Modified technique for urinary diversion with incontinent conduits.
- Port site metastasis of ovarian Carcinoma remote from laparoscopic surgery for benign disease.
- Insulinoma in Pregnancy: a case report and review of the literature.
- Papillary serous adenoCarcinoma of the ovary diagnosed after malignant pericardial tamponade and embolic stroke.
- Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian Carcinoma during the drug shortage era.
- Retreatment with bevacizumab in patients with Gynecologic malignancy is associated with clinical response and does not increase morbidity.
- Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Onco...
- Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of Cervical cancer using a hybrid magnetic resonance imaging/computed tomog...
- Kielland vs. nonrotational forceps for the second stage of labor.
- Recurrent metastatic vulvar Carcinoma treated with cisplatin plus cetuximab.
- Hematologic changes after splenectomy for cytoreduction: implications for predicting infection and effects on chemotherapy.
- Uterine adenosarcoma with sarcomatous overgrowth versus Uterine carcinosarcoma: comparison of treatment and survival.
- Cervical adenoCarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease.
- Large cell neuroendocrine cervical Carcinoma: a report of two cases and review of the literature.
- Abnormal fragile histidine triad (FHIT) expression in advanced cervical Carcinoma: a poor prognostic factor.
- Primary appendiceal malignancy mimicking advanced stage ovarian Carcinoma: a case series.
- Conservative management of isolated posthysterectomy fever.
- Recurrent invasive adenoCarcinoma after hysterectomy for cervical adenoCarcinoma in situ.
- Stump the professor.
- Gynecologic malignancies in women aged less than 25 years.
- Cecal perforation complicating placement of a transvaginal tension-free vaginal tape.
- Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cis...
- Noninvasive assessment of cell proliferation in ovarian Cancer using [18F] 3''deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging.
Schools
Oh State Univ Coll Of Med and Pub Hlth
David Grant Med Ctr
Walter Reed Army Medical Center
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Conditions Treated
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Regional Top Doctor
- Most Compassionate Doctor
- Fellow (FACOG)
Education
-
David Grant Medical Center -
The Ohio State University College of Medicine
Drug Facts
| NPI NUMBER | 1609840057 | |
| NPPES Provider LastName | KRIVAK | |
| NPPES Provider FirstName | THOMAS | |
| NPPES Provider ZIPCode | 16046 | |
| NPPES Provider State | PA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 175.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 13.0 | |
| Percent Opioid Claims | 7.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609840057 |
| Last Name Of The Provider | KRIVAK |
| First Name Of The Provider | THOMAS |
| View All |
Similar Doctors
|
Dr. Frank J. Brooks, DO
 This Doctor is OpenDoctor Recommended.
|